– CANADA, Winnipeg – Cubresa Inc., a world leader in brain imaging, today announced the appointments of Ryan Klassen and Trudy Martens to its Board of Directors.
“We welcome Ryan and Trudy on the Cubresa Board. These individuals will add tremendous value to the organization as we enter this next phase of growth. We look forward to the additional expertise they will offer the team over the coming years,” said Founder and CEO, Dr. James Schellenberg.
About Ryan Klassen
Ryan Klassen, the VP of Enterprise Sales West & Vice-Chair of Bell MTS & Western Canada, is a 25-year veteran of the Canadian communications and technology industries. In his role, Ryan Klassen is championing Bell’s commitment to advancing communications innovation and competition in the West. Ryan Klassen is an active leader in the community, serving on many business associations and charity organizations including the boards of Manitoba Technology Accelerator, the Winnipeg Chamber of Commerce, and several start-up companies.
About Trudy Martens
Until January 2022, Trudy Martens was a Senior Manager with Deloitte’s Assurance and Advisory practice where she specialized in providing accounting, auditing, and business advisory services to private companies, not-for-profit organizations, and public sector entities. During over 30 years in public practice, Trudy Martens dealt with senior management and finance teams, as well as business owners, Finance Committees, and Boards of the organizations she served.
About Cubresa Inc.
Cubresa is a world leader in designing and developing clinical and preclinical PET inserts for MRI. Cubresa products enable medical professionals at leading universities, hospitals, and pharmaceutical companies to visualize and measure biochemical processes at the molecular level.
For more information: https://www.cubresa.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
